![]() ![]() |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| A special project of the Michigan Diabetes Outreach Network |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chapter
11 Self-monitoring of blood glucose (SMBG) allows persons with diabetes to evaluate their individual response to therapy and assess whether glycemic targets are being met. Results of SMBG can be useful in preventing hypoglycemia and adjusting medications, medical nutrition therapy (MNT) and physical activity. The frequency and timing of SMBG should be determined by individual needs and goals of each person with diabetes.
Another test of glycemic control is the A1C test, which measures the average blood glucose control over the past 2-3 months. See table below for the correlation between A1C level and mean plasma glucose.
Blood glucose and A1C goals must be individualized based on age, ability to recognize hypoglycemia, history of hypoglycemia and self-management capabilities. This is especially important for children, adolescents, pregnant women and older adults. More stringent goals (A1C <6%) may further reduce complications at the cost of increased risk of hypoglycemia, especially in those with type 1 diabetes. Less stringent goals are be indicated in those with severe or frequent hypoglycemia. See table below for target blood glucose and A1C goals for persons with diabetes. Target Glycemic Goals for Persons with Diabetes
* American
Diabetes Association |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| References: American Diabetes Association (2003). Clinical Practice Recommendations, 2003. Diabetes Care, Vol 26 (1). |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||